Unlock stock picks and a broker-level newsfeed that powers Wall Street.

NYSE - Delayed Quote USD

IMAX Corporation (IMAX)

25.65
+0.62
+(2.48%)
At close: May 7 at 4:00:02 PM EDT
26.33
+0.68
+(2.65%)
Pre-Market: 4:51:04 AM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 86.67M
Earnings 7.18M

Q2'24

Q3'24

Q4'24

Q1'25

0
20M
40M
60M
80M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

16.00 Low
29.60 Average
25.65 Current
35.00 High

Earnings Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 7667
Avg. Estimate 0.20.331.191.36
Low Estimate 0.050.270.961.15
High Estimate 0.290.431.341.56
Year Ago EPS 0.180.350.951.19

Revenue Estimate

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
No. of Analysts 1010109
Avg. Estimate 92.43M101.42M404.52M425.46M
Low Estimate 83.94M89.49M390.09M406.3M
High Estimate 99.9M115.45M427.69M437.38M
Year Ago Sales 88.96M91.45M352.21M404.52M
Sales Growth (year/est) 3.90%10.90%14.85%5.17%

Earnings History

Currency in USD 6/30/2024 9/30/2024 12/31/2024 3/31/2025
EPS Est. 0.060.240.280.11
EPS Actual 0.180.350.270.13
Difference 0.120.11-0.010.02
Surprise % 198.85%48.13%-4.25%14.41%

EPS Trend

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Current Estimate 0.20.331.191.36
7 Days Ago 0.220.321.241.43
30 Days Ago 0.20.31.251.49
60 Days Ago 0.20.31.251.49
90 Days Ago 0.250.311.291.44

EPS Revisions

Currency in USD Current Qtr. (Jun 2025)Next Qtr. (Sep 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days 123--
Up Last 30 Days 1222
Down Last 7 Days 1113
Down Last 30 Days 2224

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
IMAX 11.96%-4.65%24.95%14.21%
S&P 500 12.50%3.24%7.95%13.84%

Upgrades & Downgrades

Maintains Macquarie: Outperform to Outperform 4/25/2025
Maintains Wells Fargo: Overweight to Overweight 4/24/2025
Maintains Barrington Research: Outperform to Outperform 4/24/2025
Maintains Rosenblatt: Buy to Buy 4/24/2025
Maintains JP Morgan: Neutral to Neutral 4/11/2025
Reiterates Benchmark: Buy to Buy 4/10/2025

Related Tickers